Supernus Pharmaceuticals, Inc. SUPN
42.66
(0.63)
(1.46%)
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 0.0×
Follow SUPN
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
14.10 | 35.80 | 15.52 | 11.03 | 10.44 | 28.59 | 33.16 | 1,118.15 | 26.94 | 0.00 |
P/S ratio |
5.97 | 6.79 | 4.22 | 3.17 | 2.54 | 2.67 | 3.01 | 2.49 | 3.01 | 3.90 |
P/FCF ratio |
27.68 | 21.41 | 13.65 | 8.87 | 9.94 | 12.54 | 17.51 | 13.88 | 11.74 | 63.18 |
P/Operating CF |
51.48 | 56.51 | 52.58 | 28.39 | 41.46 | 31.75 | 72.95 | 33.64 | 44.87 | 141.26 |
P/B ratio |
6.70 | 7.68 | 3.81 | 2.09 | 1.78 | 1.90 | 2.27 | 1.64 | 1.92 | 2.64 |
Price to Tangible BV |
8.26 | 8.87 | 4.10 | 2.18 | 4.37 | 0.00 | 30.14 | 7.39 | 5.02 | 7.64 |
EV/Sales |
5.57 | 6.33 | 4.16 | 3.18 | 2.44 | 2.75 | 2.99 | 2.14 | 2.39 | 3.53 |
EV/EBITDA |
20.97 | 17.87 | 10.52 | 7.47 | 6.18 | 11.67 | 14.56 | 16.24 | 9.64 | 91.49 |
EV/Operating CF |
17.93 | 16.70 | 13.18 | 8.71 | 9.18 | 12.54 | 17.07 | 11.70 | 9.19 | 53.64 |
EV/FCF |
25.82 | 19.97 | 13.44 | 8.90 | 9.55 | 12.91 | 17.37 | 11.93 | 9.32 | 57.17 |
Quick Ratio |
1.63 | 1.67 | 2.84 | 2.71 | 2.30 | 1.55 | 0.91 | 1.38 | 2.04 | 1.47 |
Current Ratio |
1.88 | 1.86 | 3.06 | 2.94 | 2.57 | 1.91 | 1.07 | 1.70 | 2.35 | 1.90 |
Net Debt/EBITDA |
(1.50) | (1.10) | (0.16) | (0.01) | (0.30) | 0.29 | (3.10) | (3.19) | (2.77) | (11.12) |
Debt/Assets |
1.35% | 5.18% | 33.69% | 29.75% | 24.05% | 22.45% | 2.11% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.02 | 0.08 | 0.73 | 0.58 | 0.49 | 0.46 | 0.04 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.86 | 0.82 | 0.58 | 0.37 | 0.39 | 0.36 | 0.39 | 0.41 | 0.50 | 0.51 |
Operating CF/Net income |
0.73 | 2.00 | 1.16 | 1.27 | 1.09 | 2.38 | 1.82 | 84.41 | 2.33 | (1.23) |
Capex/Depreciation |
(7.00) | (0.27) | (0.05) | (0.08) | (0.12) | (0.04) | 0.00 | (0.01) | (0.01) | (0.01) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 65.21% | 24.95% | 30.81% | 21.57% | 18.94% | 6.85% | 7.55% | 0.15% | 7.55% | (3.68%) | |
| 36.62% | 15.61% | 15.83% | 10.58% | 9.53% | 3.35% | 3.79% | 0.09% | 5.58% | (2.73%) | |
ROIC |
32.03% | 41.63% | 21.17% | 15.64% | 15.87% | 6.29% | 6.26% | (0.49%) | 8.77% | (5.17%) |
Return on Tangible Assets |
121.62% | 51.81% | 33.01% | 34.35% | 30.00% | 17.62% | 104.73% | 0.61% | 18.23% | (12.18%) |
Average Days of Receivables |
70.50 | 79.21 | 91.87 | 81.16 | 98.81 | 93.76 | 90.53 | 86.61 | 78.36 | 95.34 |
Research and Development Expense of Revenue |
19.90% | 16.40% | 21.82% | 17.59% | 14.60% | 15.60% | 11.17% | 15.08% | 16.44% | 14.78% |
Selling, General and Administrative Expense of Revenue |
49.31% | 45.63% | 37.83% | 39.02% | 38.56% | 52.57% | 56.53% | 55.37% | 48.59% | 67.54% |
Intangible Assets out of Total Assets |
0.12 | 0.08 | 0.03 | 0.02 | 0.29 | 0.53 | 0.48 | 0.56 | 0.47 | 0.48 |
Share Based Compensation of Revenue |
2.76% | 2.79% | 2.76% | 3.78% | 3.18% | 3.09% | 2.63% | 4.40% | 4.19% | 4.60% |
Graham Net Nets |
0.03 | 0.03 | (0.02) | (0.07) | (0.10) | (0.18) | (0.04) | 0.09 | 0.18 | 0.09 |
Graham Number |
12.67 | 11.58 | 20.48 | 23.44 | 27.71 | 18.78 | 20.49 | 3.07 | 23.83 | 0.00 |
Earnings Yield |
7.09% | 2.79% | 6.44% | 9.06% | 9.58% | 3.50% | 3.02% | 0.09% | 3.71% | (1.37%) |
Free Cash Flow Yield |
3.61% | 4.67% | 7.33% | 11.27% | 10.06% | 7.98% | 5.71% | 7.20% | 8.51% | 1.58% |
Revenue per Share |
4.35 | 5.95 | 7.86 | 7.49 | 9.89 | 10.92 | 12.43 | 11.14 | 12.01 | 12.74 |
Operating CF per Share |
1.35 | 2.26 | 2.48 | 2.73 | 2.63 | 2.39 | 2.18 | 2.04 | 3.12 | 0.84 |
Capex per Share |
(0.41) | (0.04) | (0.02) | (0.03) | (0.07) | (0.04) | (0.01) | (0.01) | (0.01) | (0.02) |
Free Cash Flow per Share |
0.94 | 2.22 | 2.46 | 2.70 | 2.56 | 2.36 | 2.17 | 2.03 | 3.11 | 0.81 |
Cash per Share |
1.82 | 2.76 | 6.85 | 6.62 | 8.03 | 6.40 | 8.60 | 4.67 | 8.23 | 5.47 |
Shareholders Equity per Share |
3.88 | 5.27 | 8.71 | 11.36 | 14.16 | 15.36 | 16.51 | 16.90 | 18.80 | 18.81 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.88 | 5.27 | 8.71 | 11.36 | 14.16 | 15.36 | 16.51 | 16.90 | 18.80 | 18.81 |
Free Cash Flow |
46.39 | 112.61 | 128.14 | 141.74 | 134.71 | 125.08 | 116.41 | 110.53 | 171.23 | 45.99 |
Working Capital |
70.66 | 105.45 | 332.13 | 312.06 | 385.31 | 286.21 | 46.19 | 202.92 | 393.67 | 306.01 |
Capital Expenditures |
(20.42) | (2.03) | (0.84) | (1.39) | (3.69) | (2.04) | (0.41) | (0.55) | (0.72) | (1.34) |
Net Current Asset Value |
33.59 | 71.47 | (31.30) | (92.21) | (128.83) | (271.71) | (82.15) | 136.96 | 353.73 | 253.25 |
EV/EBIT |
22.09 | 19.23 | 11.77 | 8.40 | 7.32 | 18.53 | 43.24 | 0.00 | 19.36 | 0.00 |
Capex to Sales |
0.10 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
42.43% | 18.95% | 27.14% | 28.79% | 24.39% | 9.21% | 9.63% | 0.22% | 11.16% | (5.36%) |
Price to Operating Income |
23.68 | 20.63 | 11.96 | 8.37 | 7.62 | 18.00 | 43.60 | 0.00 | 24.40 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.67 | 1.49 | 4.21 | 1.07 | 0.84 | 2.98 | 5.99 | 6.30 | 7.12 | 8.55 |
Cash ROIC |
21.84% | 25.50% | 10.97% | 9.79% | 6.58% | 7.18% | 7.35% | 8.29% | 10.77% | 2.69% |
Accounts Receivable Turnover |
6.38 | 5.64 | 4.85 | 4.13 | 4.56 | 4.00 | 4.24 | 3.92 | 4.62 | 4.36 |
Accounts Payable Turnover |
1.94 | 2.04 | 3.06 | 0.63 | 0.82 | 0.76 | 0.82 | 0.95 | 1.00 | 0.81 |
Inventory Turnover |
0.82 | 0.92 | 0.73 | 0.64 | 1.40 | 1.12 | 0.98 | 0.99 | 1.18 | 1.09 |
Average Days of Payables |
245.29 | 164.18 | 75.94 | 1,089.17 | 549.21 | 572.26 | 403.17 | 346.66 | 357.72 | 527.71 |
Days of Inventory on Hand |
511.63 | 391.12 | 609.89 | 583.39 | 336.24 | 417.99 | 383.08 | 337.24 | 254.37 | 403.30 |
Average Receivables |
33.72 | 53.56 | 84.25 | 95.13 | 114.10 | 144.90 | 157.21 | 154.83 | 143.12 | 164.94 |
Average Payables |
6.18 | 7.45 | 5.02 | 26.45 | 64.32 | 98.31 | 107.01 | 87.96 | 77.96 | 92.08 |
Average Inventory |
14.69 | 16.55 | 20.98 | 26.14 | 37.48 | 67.14 | 88.75 | 84.47 | 65.85 | 68.34 |
Average Assets |
249.10 | 367.02 | 701.14 | 1,069.05 | 1,332.19 | 1,596.63 | 1,695.83 | 1,490.09 | 1,322.87 | 1,410.36 |
Average Common Equity |
139.88 | 229.62 | 360.25 | 524.23 | 670.14 | 780.35 | 851.03 | 903.86 | 978.62 | 1,048.72 |
Columns are period end dates